FK506 reduces albuminuria through improving podocyte nephrin and podocin expression in diabetic rats

OBJECTIVE AND DESIGN: Several works in the setting of early experimental diabetic nephropathy using anti-inflammatory drugs, such as the calcineurin inhibitor FK506, have shown prevention of the development or amelioration of renal injury including proteinuria. The exact mechanisms by which anti-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, X.-M., Wang, J., Xu, X.-X., Li, Y.-Y., Wu, Y.-G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712236/
https://www.ncbi.nlm.nih.gov/pubmed/26566632
http://dx.doi.org/10.1007/s00011-015-0893-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712236/
https://www.ncbi.nlm.nih.gov/pubmed/26566632
http://dx.doi.org/10.1007/s00011-015-0893-y

Ejemplares similares